Cargando…

Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series

BACKGROUND: Stereotactic body radiotherapy (SBRT) is an emerging modality for hepatocellular carcinoma (HCC). However, there is scant information about its safety and effectiveness in the neoadjuvant setting prior to liver transplantation (LT). We present the clinical outcome and pathologic assessme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying-Fu, Dai, Yang-Hong, Lin, Chun-Shu, Chang, Hao-Chih, Shen, Po-Chien, Yang, Jen-Fu, Hsiang, Chih-Weim, Lo, Cheng-Hsiang, Huang, Wen-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807861/ https://www.ncbi.nlm.nih.gov/pubmed/33446231 http://dx.doi.org/10.1186/s13014-020-01739-5

Ejemplares similares

Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
por: Hsiang, Chih-Weim, et al.
Publicado: (2021)

Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2019)

Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma
por: Yang, Jen-Fu, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
por: Yang, Jen-Fu, et al.
Publicado: (2019)

Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2017)

Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy
por: Shen, Po-Chien, et al.
Publicado: (2022)

Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma
por: Garg, Rashi, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy as a Bridge to Transplantation and for Recurrent Disease in the Transplanted Liver of a Patient with Hepatocellular Carcinoma
por: Mazloom, Ali, et al.
Publicado: (2014)

Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series
por: Wong, Ta-Hsiang, et al.
Publicado: (2022)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
por: Moore, Assaf, et al.
Publicado: (2017)

Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
por: Wong, Tiffany Cho‐Lam, et al.
Publicado: (2021)

Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer
por: Dai, Yang-Hong, et al.
Publicado: (2021)

Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
por: Dai, Yang-Hong, et al.
Publicado: (2021)

Determinants of Receiving the Pandemic (H1N1) 2009 Vaccine and Intention to Receive the Seasonal Influenza Vaccine in Taiwan
por: Chan, Ta-Chien, et al.
Publicado: (2014)

What if a tumor is significantly enlarged just before stereotactic body radiation therapy? A case report and review of the literature
por: Chen, Hung‐Jen, et al.
Publicado: (2016)

Radiation doses with various body weights of phantoms in brain 128-slice MDCT examination
por: Lin, Hung-Chih, et al.
Publicado: (2019)

Representative Contact Diaries for Modeling the Spread of Infectious Diseases in Taiwan
por: Fu, Yang-chih, et al.
Publicado: (2012)

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)

Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study
por: Huang, Wan-Ting, et al.
Publicado: (2013)

Successful Treatment of Infantile Fibrosarcoma Spinal Metastasis by Chemotherapy and Stereotactic Hypofractionated Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
por: Schaub, Stephanie K., et al.
Publicado: (2018)

The Current Diagnostic Accuracy on Free Peritoneal Fluid in Computed Tomography to Determinate the Necessity of Surgery in Blunt Bowel and Mesenteric Trauma—Systemic Review and Meta-Analysis
por: Chen, Szu-An, et al.
Publicado: (2021)

Taiwan cobra envenoming: serum venom concentration before and after specific treatment and relationship with debridement of necrotic wound tissue
por: Wang, Chia-Cheng, et al.
Publicado: (2023)

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade
por: Ho, Shu-Yein, et al.
Publicado: (2020)

Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells
por: Chen, Hsin-An, et al.
Publicado: (2021)

Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer
por: Huang, Tai-Lin, et al.
Publicado: (2022)

Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?
por: Tan, Chun Han Nigel, et al.
Publicado: (2018)

Levitronix bilateral ventricular assist device, a bridge to recovery in a patient with acute fulminant myocarditis and concomitant cerebellar infarction
por: Yi-Fan, Huang, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Novel application of stereotactic ablative radiotherapy using CyberKnife(®) for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences
por: LO, CHENG-HSIANG, et al.
Publicado: (2014)

Clinical Features and Computed Tomography Characteristics of Non-Klebsiella pneumoniae Liver Abscesses in Elderly (>65 Years) and Nonelderly Patients
por: Hsiang, Chih-Weim, et al.
Publicado: (2015)

Impact of the Pre-Transplant Circulatory Supportive Strategy on Post-Transplant Outcome: Double Bridge May Work
por: Chou, Nai-Kuan, et al.
Publicado: (2021)

Pathological humerus fracture due to anti-interferon-gamma autoantibodies: A case report
por: Yang, Cheng Hsun, et al.
Publicado: (2021)

MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma
por: Yue, Chia-Herng, et al.
Publicado: (2015)

Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology
por: Chuang, Ching-Yu, et al.
Publicado: (2019)

Correction: MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma
por: Yue, Chia-Herng, et al.
Publicado: (2015)

A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
por: Lin, Chih-Lang, et al.
Publicado: (2023)

Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma
por: Yu, Yung-Luen, et al.
Publicado: (2013)

Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning
por: Fredman, Elisha, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for Recurrent, Isolated Hepatocellular Carcinoma Lymph Node Metastasis With or Without Prior Liver Transplantation
por: Walburn, Tyler, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mmt8ck9b6vb1do569tqekj89ne